Table 3.
Efficacy Of Apatinib In Patients With Cervical Cancer
| n=25 | 95% CI | |
|---|---|---|
| Median PFS (months) | 5.8 | 4.65–6.95 |
| Median OS (months) | 12.2 | 8.99–15.41 |
| Tumor response | ||
| PR (%) | 12 (48) | |
| SD (%) | 12 (48) | |
| PD (%) | 1 (4) | |
| ORR | 48% | |
| DCR | 96% |
Abbreviations: PFS, progression-free survival; OS, overall survival; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; CI, confidence interval.